Wednesday, November 4, 2026Updated every morning at 5:30 AM ET
NanotechProgress

April 2019

1 dated step on the record this month, newest first.

  • MedicineApprovalCompany-reported

    NBTXR3

    Nanobiotix said its product, sold under the name Hensify, won a CE mark in Europe for locally advanced soft tissue sarcoma.

    Approved or on sale